RxDoctor Payments Data

George Abraham, MD

Family Medicine · Vicksburg, MSNPI 1184669798

Payments from drug & device makers

$8,896in general payments, 2019–2025

Across 124 payments — averaging $71.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals AS$7K
  • Novo Nordisk$487
  • GSK$250
  • AbbVie$235
  • Abbott$163
  • Alpha Cognition USA, Inc.$125
  • plus $596 from 15 others

What the payments were for

  • Food & beverage$1,856100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,896 in reported general payments places this provider in the 90th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$25,943
Medicare patients
109
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban87$62,345
JardianceEmpagliflozin52$55,781
OzempicSemaglutide44$54,790
XifaxanRifaximin12$36,858
LinzessLinaclotide51$28,307
EntrestoSacubitril/Valsartan17$27,590
TrulicityDulaglutide26$25,051
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$24,948
Tresiba Flextouch U-100Insulin Degludec19$18,713
SymbicortBudesonide/Formoterol Fumarate20$7,529
MyrbetriqMirabegron13$5,804
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,659
MovantikNaloxegol Oxalate12$4,798
Gabapentin339$4,255
ZenpepLipase/Protease/Amylase11$3,949

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38$62,34587 claims
Boehringer IngelheimJardiance$56$55,78152 claims
Novo NordiskOzempic$487$54,79044 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$11$36,85812 claims
GSKTrelegy Ellipta, Anoro Ellipta$250$30,60843 claims
AbbVieLinzess$235$28,30751 claims
Lilly USA, LLCTrulicity, Olanzapine$42$28,20755 claims
NovartisEntresto$15$27,59017 claims
AstraZenecaSymbicort$57$7,52920 claims
Astellas Pharma US IncMyrbetriq$95$5,80413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Vicksburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →